1. Home
  2. CDTX vs HOND Comparison

CDTX vs HOND Comparison

Compare CDTX & HOND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDTX
  • HOND
  • Stock Information
  • Founded
  • CDTX 2012
  • HOND 2024
  • Country
  • CDTX United States
  • HOND United States
  • Employees
  • CDTX N/A
  • HOND N/A
  • Industry
  • CDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • HOND
  • Sector
  • CDTX Health Care
  • HOND
  • Exchange
  • CDTX Nasdaq
  • HOND NYSE
  • Market Cap
  • CDTX 980.1M
  • HOND 334.9M
  • IPO Year
  • CDTX 2015
  • HOND 2024
  • Fundamental
  • Price
  • CDTX $55.85
  • HOND $11.24
  • Analyst Decision
  • CDTX Strong Buy
  • HOND
  • Analyst Count
  • CDTX 11
  • HOND 0
  • Target Price
  • CDTX $52.11
  • HOND N/A
  • AVG Volume (30 Days)
  • CDTX 1.5M
  • HOND 331.5K
  • Earning Date
  • CDTX 08-12-2025
  • HOND 01-01-0001
  • Dividend Yield
  • CDTX N/A
  • HOND N/A
  • EPS Growth
  • CDTX N/A
  • HOND N/A
  • EPS
  • CDTX N/A
  • HOND 0.20
  • Revenue
  • CDTX $302,000.00
  • HOND N/A
  • Revenue This Year
  • CDTX N/A
  • HOND N/A
  • Revenue Next Year
  • CDTX N/A
  • HOND N/A
  • P/E Ratio
  • CDTX N/A
  • HOND $54.58
  • Revenue Growth
  • CDTX N/A
  • HOND N/A
  • 52 Week Low
  • CDTX $10.14
  • HOND $9.90
  • 52 Week High
  • CDTX $56.83
  • HOND $12.24
  • Technical
  • Relative Strength Index (RSI)
  • CDTX 71.30
  • HOND N/A
  • Support Level
  • CDTX $50.25
  • HOND N/A
  • Resistance Level
  • CDTX $55.75
  • HOND N/A
  • Average True Range (ATR)
  • CDTX 3.87
  • HOND 0.00
  • MACD
  • CDTX -0.26
  • HOND 0.00
  • Stochastic Oscillator
  • CDTX 72.36
  • HOND 0.00

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

About HOND HCM II ACQUISITION CORP

HCM II Acquisition Corp is a blank check company.

Share on Social Networks: